Detalles de la búsqueda
1.
[Follicle-Stimulating Hormone and Estradiol Levels in Japanese Women Treated with Toremifene and Anastrozole for Two Years - A Retrospective Analysis of Data from a Prospective Randomized Trial].
Gan To Kagaku Ryoho
; 45(12): 1725-1728, 2018 Dec.
Artículo
en Japonés
| MEDLINE | ID: mdl-30587728
2.
[An Elderly Patient with Metastatic Breast Cancer Who Developed Severe Adverse Events such as Stomatitis and Interstitial Pneumonia after Everolimus plus Exemestane Treatment].
Gan To Kagaku Ryoho
; 43(6): 753-5, 2016 Jun.
Artículo
en Japonés
| MEDLINE | ID: mdl-27306814
3.
[A Case of Recurrent Breast Cancer with Carcinomatous Pleurisy Successfully Treated with Biweekly Paclitaxel and Bevacizumab].
Gan To Kagaku Ryoho
; 43(11): 1397-1400, 2016 Nov.
Artículo
en Japonés
| MEDLINE | ID: mdl-27899783
4.
Effects of toremifene and anastrozole on serum lipids and bone metabolism in postmenopausal females with estrogen receptor-positive breast cancer: the results of a 2-year multicenter open randomized study.
Breast Cancer Res Treat
; 128(3): 775-81, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21638048
5.
Effects of toremifene and tamoxifen on lipid profiles in post-menopausal patients with early breast cancer: interim results from a Japanese phase III trial.
Jpn J Clin Oncol
; 40(7): 627-33, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20382637
6.
[Efficacy of treatment with high-dose toremifene in patients with metastatic breast cancer resistant to aromatase inhibitor treatment].
Gan To Kagaku Ryoho
; 36(6): 1013-6, 2009 Jun.
Artículo
en Japonés
| MEDLINE | ID: mdl-19542727
7.
Neoadjuvant paclitaxel for operable breast cancer: multicenter phase II trial with clinical outcomes.
Anticancer Res
; 28(2B): 1239-44, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18505061
8.
Higher efficacy and complete response with administration of eribulin for recurrent squamous cell breast carcinoma: A case report.
Mol Clin Oncol
; 9(3): 318-320, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-30155255
9.
Phase II Study of S-1 plus Trastuzumab for HER2-positive Metastatic Breast Cancer (GBCCSG-01).
Anticancer Res
; 38(2): 905-909, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29374719
10.
Serum lipid and bone metabolism effects of Toremifene vs. Letrozole as adjuvant therapy for postmenopausal early breast cancer patients: results of a multicenter open randomized study.
Cancer Chemother Pharmacol
; 81(2): 269-275, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29196963
11.
Toremifene: an evaluation of its safety profile.
Breast
; 15(2): 142-57, 2006 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-16289904
12.
Increased nuclear localization of transcription factor Y-box binding protein 1 accompanied by up-regulation of P-glycoprotein in breast cancer pretreated with paclitaxel.
Clin Cancer Res
; 11(24 Pt 1): 8837-44, 2005 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16361573
13.
Combination docetaxel and trastuzumab treatment for patients with HER-2-overexpressing metastatic breast cancer: a multicenter, phase-II study.
Breast Cancer
; 13(2): 166-71, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16755112
14.
[Multicenter phase II trial of thrice-weekly docetaxel and weekly trastuzumab as preoperative chemotherapy in patients with HER 2-overexpressing breast cancer--Japan East Cancer Center Breast Cancer Consortium (JECBC) 02 Trial].
Gan To Kagaku Ryoho
; 33(10): 1411-5, 2006 Oct.
Artículo
en Japonés
| MEDLINE | ID: mdl-17033229
15.
[Study of three-weekly docetaxel and weekly trastuzumab treatment in HER 2-overexpressing metastatic breast cancer patients].
Gan To Kagaku Ryoho
; 32(3): 335-9, 2005 Mar.
Artículo
en Japonés
| MEDLINE | ID: mdl-15791816
16.
[Late phase II clinical study of KW-2307 in advanced/recurrent breast cancer patients (II)].
Gan To Kagaku Ryoho
; 32(7): 983-90, 2005 Jul.
Artículo
en Japonés
| MEDLINE | ID: mdl-16044960
17.
Mutation of the class I beta-tubulin gene does not predict response to paclitaxel for breast cancer.
Cancer Lett
; 198(1): 89-97, 2003 Jul 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-12893435
18.
Pharmacokinetic and pharmacodynamic study of IST-622, a novel synthetic derivative of chartreusin, by oral administration in a phase II study of patients with breast cancer.
Cancer Chemother Pharmacol
; 49(6): 468-72, 2002 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-12107551
19.
1-hexylcarbamoyl-5-fluorouracil + cyclophosphamide + tamoxifen versus CMF + tamoxifen in women with lymph node-positive breast cancer after primary surgery: a randomized controlled trial.
Oncol Rep
; 12(4): 797-803, 2004 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-15375502
20.
Combination chemotherapy with docetaxel and doxifluridine showed a beneficial outcome in advanced or recurrent breast cancer patients with longer disease-free interval.
Anticancer Res
; 24(3b): 2085-91, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15274405